...
【24h】

Inter-hospital extracorporeal life support

机译:院际体外生命支持

获取原文

摘要

Cardiogenic shock is the leading cause of death for patients with acute myocardial infarction who reach the hospital alive. It affects about 6 to 8% of patients with acute myocardial infarction. [1] Despite the advantages of early intra-aortic balloon pump (IABP), fibrinolysis, percutaneous coronary intervention or coronary arterial bypass graft , once shock is diagnosed, the mortality remains high (about 50%) with half of death occurring during the first 48 hours [2]. Some studies suggested that haemodynamic and metabolic parameters could be more effectively reversed by ventricular assist device than by standard treatment with IABP [3]. In this investigation we report our experience of using extracorporeal membrane oxygenation (ECMO) to resuscitate a 60-year-old man with critical left main coronary artery disease complicated by acute myocardial infarction (AMI) and cardiogenic shock. The connection of patient to ECMO circuit was performed in an hospital other than ours and the patient was then transported to our hospital on ECMO with an Advanced Care Mobile Unit.
机译:心源性休克是存活到医院的急性心肌梗死患者的主要死亡原因。它影响约6至8%的急性心肌梗死患者。 [1]尽管早期主动脉内气囊泵(IABP),纤维蛋白溶解,经皮冠状动脉介入治疗或冠状动脉搭桥术具有优势,但一旦确诊为休克,死亡率仍然很高(约50%),其中一半死亡发生在第一次48小时[2]。一些研究表明,与IABP的标准治疗相比,心室辅助装置可以更有效地逆转血流动力学和代谢参数[3]。在这项调查中,我们报告了使用体外膜氧合作用(ECMO)复苏一名60岁重症左主冠状动脉疾病并发急性心肌梗塞(AMI)和心源性休克的人的经验。患者与ECMO回路的连接是在我们医院以外的医院进行的,然后使用高级护理移动装置将患者通过ECMO运送到我们医院。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号